Device Trial Radar · NCT06636539
Prospective Case Collection Study of Contrast-Enhanced Mammography Imaging Acquired on a New Investigational Device
Last checked: Nov 20, 2026Latest source record: Jun 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
75
Planned (sponsor's estimate)
Start
Oct 14, 2024
Primary completion
Nov 5, 2026
Study completion Nov 5, 2026
Sponsor
- Lead sponsor
- Hologic, Inc.Public (HOLX)
- Sponsor type
- Industry
- First posted
- Oct 10, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Screening
- FDA-regulated device
- Yes
- Who can join
- Female only, from 35 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a prospective, multi-center image case collection study to acquire de-identified contrast-enhanced breast images on a mammography device to support continuing software technology development. Eligible subjects include women at least 35 years old with a suspicious finding or breast abnormality on a screening or diagnostic mammogram who are indicated for a diagnostic exam or a biopsy procedure.
Conditions
- Breast Screening
Interventions
CEM Software in New Mammography DeviceDevice
All subjects enrolled in the study will undergo a CEM exam.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of subjects (cases) with lesionsTime frame: 18 months
Locations
2 sites in 1 country. Site status is shown where the registry gives one.
Solis Mammography Memorial Village
Houston, Texas
Washington Radiology Sterling
Sterling, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.